Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New drug combination prevents breast cancer growth pre-surgery


A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs. A London-based group of scientists, reporting today (Tuesday 17 May) in The Lancet Oncology, say that taking the new drug combination prior to surgery could make breast cancer surgery less invasive and more effective, and reduce the risk of cancer spreading to other parts of the body.

Around 80% of breast cancers depend on the hormone oestrogen to survive, and removing oestrogen from the body is standard treatment for the disease. However, only half of primary breast cancers respond well to this therapy, leading doctors to use more toxic chemotherapy, which causes many side effects. The researchers have found that by combining existing oestrogen-blocking drugs with a new drug called gefitinib that blocks another receptor on the cancer cell surface, tumour growths shrink more rapidly and to a smaller size.

The study followed 56 post-menopausal women who had cancer cells with oestrogen receptors (ER) and epidermal growth factor receptors (EGFR). Half received the oestrogen-blocker anastrozole and the EGFR-blocker gefitinib, the other half received gefitinib and a placebo. Treatment was for 4-6 weeks, prior to surgery to remove the cancer.

Levels of a molecule that indicates cell proliferation, Ki67, were reduced in both groups. Tumour size was reduced substantially in 14 of the 28 patients assigned both anastrozole and gefitinib, and in 12 of 22 assigned gefitinib alone.

"The presence or EGFR seems to be one of the reasons that standard oestrogen-blockers do not always work in ER-positive breast cancers," comments Professor Charles Coombes, head of cancer medicine at Hammersmith Hospitals NHS Trust and Imperial College London. "In women that are resistant to anti-oestrogen therapy, it may provide a ’back door’ mechanism for cancer cell proliferation. Targeting both these receptors seems to increase the effectiveness of treatment."

"The significant reduction in tumour size, combined with minimal side-effects, makes this an exciting prospect for pre-surgery cancer treatment. We are currently designing larger studies to verify this approach."

Simon Wilde | alfa
Further information:

More articles from Health and Medicine:

nachricht Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Ice shelf vibrations cause unusual waves in Antarctic atmosphere

25.10.2016 | Earth Sciences

Fluorescent holography: Upending the world of biological imaging

25.10.2016 | Power and Electrical Engineering

Etching Microstructures with Lasers

25.10.2016 | Process Engineering

More VideoLinks >>>